,i  #aah? ,,congress  #b;d ,session  ,h4
 ,r4 #icba  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,augu/ #f1 #bjbd,ms4  
,slotk9 7= h]self & ,mr4 ,bacon7        
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce1 & 9 
addition to ! ,committee on ,ways &     
,means1 = a p]iod to be subsequ5tly     
det]m9$ by ! ,speak]1 9 ea* case =      
consid]ation ( su* provisions z fall )9 
! jurisdiction ( ! committee conc]n$  ,a
 ,,bill  ,to direct ! ,secret>y ( ,heal?
 & ,human ,s]vices to conduct a         
demon/ration program to te/ provid+     
pref]5tial treatm5t "u ! ,m$ic>e1       
,m$icaid1 & ,,*ip programs = c]ta9 drugs
 & biologicals manufactur$ 9 ! ,unit$   
,/ates4  #a4 ,%ort title ,?is ,act may  
be cit$ z ! ,am]ican ,made              
,ph>maceuticals ,act ( #bjbd4  #b4      
,demon/ration program to te/ provid+    
pref]5tial treatm5t "u ! ,m$ic>e1       
,m$icaid1 & ,,*ip programs = c]ta9 drugs
 & biologicals manufactur$ 9 ! ,unit$   
,/ates ,"p ,a ( title ,,xi ( ! ,social  

,security ,act 7#db ,u4,s4,c4 #acja et  
seq47 is am5d$ by ins]t+ aft] section   
#aaej;,c ! foll[+3  #aaej;,d4           
,demon/ration program to te/ provid+    
pref]5tial treatm5t "u ! ,m$ic>e1       
,m$icaid1 & ,,*ip programs = c]ta9 drugs
 & biologicals manufactur$ 9 ! ,unit$   
,/ates  7a7 ,9 g5]al ,n lat] ?an #a ye> 
aft] ! date ( enactm5t ( ?is section1 ! 
,secret>y %all conduct a demon/ration   
program 79 ?is section ref]r$ to z !    
,program7 "u :i* ,u4,s4 manufactur$     
drugs are giv5 pref]5ce "u titles       
,,xviii1 ,,xix1 & ,,xxi comp>$ to drugs 
t are n ,u4,s4 manufactur$ drugs ?r\gh !
 use ( applicable tools4  7b7 ,sites ,! 
,program %all be conduct$ 9 at lea/ #h  
,/ates4  7c7 ,duration ,! ,secret>y %all
 conduct ! ,program = a p]iod ( n less  
?an #g ye>s4  7d7 ,def9itions ,9 ?is    
section3 7#a7 ,applicable drug ,! t]m   
applicable drug means-- 7,a7 a drug t is
 approv$ & m>ket$ "u section #eje7;j7 ( 
! ,f$]al ,food1 ,drug1 & ,cosmetic ,act2
  7,b7 a biological product t is lic5s$ 

& m>ket$ "u section #cea7k7 ( ! ,public 
,heal? ,s]vice ,act2 or  7,c7 a critical
 drug4  7#b7 ,applicable ,u4,s4-bas$    
ph>maceutical company ,! t]m applicable 
,u4,s4-bas$ ph>maceutical company means 
a manufactur] 7z def9$ 9 section        
#ahfj;,d-#ad;,a7g77#e77-- 7,a7 t has a  
manufactur+ location 9 ! ,unit$ ,/ates =
 an applicable drug2  7,b7 beg9n+ #c    
ye>s aft] ! date ( ! implem5tation ( !  
,program1 = :i* at lea/ #ej p]c5t ( !   
/>t] products1 by weight1 = ! applicable
 drugs manufactur$ by ! manufactur] are 
d]iv$ f c\ntries o!r ?an cov]$ nations  
7z def9$ 9 section #dhga7;d77#b7 ( title
 #aj1 ,unit$ ,/ates ,code72 &  7,c7 t1 z
 det]m9$ by ! ,secret>y-- 7i7 ma9ta9s an
 appropriate level ( transp>5cy on      
locations ( manufactur+2  7ii7 ma9ta9s  
an appropriate level ( div]sity 9 s\rc+2
  7iii7 ma9ta9s appropriate levels (    
inv5tory & em]g5cy res]ves2  7iv7 has 9 
place an appropriate action plan =      
increases 9 dem& & = :5 l9ks 9 ! supply 
*a9 break d[n2 &  7v7 meets any o!r     

*>act]i/ics ! ,secret>y det]m9es        
appropriate4  7#c7 ,applicable tools ,! 
t]m applicable tools means tools det]m9$
 appropriate by ! ,secret>y1 su* z--    
7,a7 pref]5tial treatm5t on a =mul>y2   
7,b7 provid+ l[] co/-%>+2  7,c7 waiv+   
rebates "u ! ,m$icaid program "u title  
,,xix2  7,d7 e/abli%+ a ,m$ic>e ,/>     
,rat+ "u "p ,d ( title ,,xviii2 or  7,e7
 provid+ bonus paym5ts to provid]s (    
s]vices & suppli]s "u "p ,b ( title     
,,xviii4  7#d7 ,critical drug ,9 ?is    
section1 ! t]m critical drug includes ! 
foll[+3 7,a7 ,a m$ic9e1 m$ical          
c\nt]measure1 or critical input id5tifi$
 on ! li/ "u section #c7;c7 ( ,executive
 ,ord] #acidd ( ,augu/ #f1 #bjbj 7#he   
,f$4 ,reg #diibi2 relat+ to ess5tial    
m$ic9es1 m$ical ,c\nt]measures1 &       
critical inputs74  7,b7 ,a drug or      
biological t-- 7i7 is n describ$ 9      
subp>agraph 7,a72  7ii7 is approv$ &    
m>ket$ "u section #eje7;c7 ( ! ,f$]al   
,food1 ,drug1 & ,cosmetic ,act or is    
lic5s$ & m>ket$ "u section #cea7;a7 ( ! 

,public ,heal? ,s]vice ,act 7or is an   
active ph>maceutical +r$i5t ( su* a drug
 or biological72  7iii7 ! ,secret>y     
det]m9es-- 7,i7 is-- 7aa7 likely to be  
ne$$ = use 9 a public heal? em]g5cy2 or 
7bb7 at high risk ( %ort supply2 &      
7,,ii7 has a vuln]able global supply    
*a94  7#e7 ,u4,s4 manufactur$ drug ,!   
t]m ,u4,s4 manufactur$ drug means an    
applicable drug t is manufactur$ 9 !    
,unit$ ,/ates by an applicable          
,u4,s4-bas$ ph>maceutical company4  7e7 
,annual report to ,congress ,n lat] ?an 
#a ye> aft] ! date ! ,secret>y implem5ts
 ! ,program1 & annually !reaft] = z long
 z ! ,program is be+ conduct$1 !        
,secret>y %all submit to ,congress a    
report on activities "u ! ,program1     
toge!r ) recomm5dations = su*           
legislation & adm9i/rative action z !   
,secret>y det]m9es to be appropriate4   
7f7 ,waiv]s ,! ,secret>y may waive su*  
provisions ( ?is title & titles ,,xviii1
 ,,xix1 & ,,xxi z ! ,secret>y det]m9es  
necess>y 9 ord] to implem5t ! ,program4 

7g7 ,adm9i/rative fund+ ,!re is au?oriz$
 to be appropriat$ to ! ,secret>y su*   
sums z may be necess>y = ! adm9i/rative 
exp5ses ( c>ry+ out ! ,program1 to rema9
 available until exp5d$4  4